← Leaderboards
Aryeh Hurwitz
University Of Kansas Medical Center
$1,674,654
Attributed
$1,674,654
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,674,654 · 3
By mechanism
R01$1,674,654 · 1
N01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Lauren M Aleksunes$14,275,663
- Jill C. Pelling$5,299,767
- Paul Toren$553,203
- John Mark Perry$992,378
- Sarah A Taylor$815,756
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase IPharmacokineticsPlant ExtractsGlutathione TransferaseHuman SubjectMedicinal PlantsNad(P)H DehydrogenasePatient Oriented ResearchAlternative MedicineCognitionCytochrome P450Drug Adverse EffectDrug InteractionsDrug MetabolismEnzyme ActivityGinkgo BilobaClinical ResearchAntineoplasticsDrug Screening /EvaluationDosageHuman DataModel Design /Development
Grant awards (5)
Effects of Ginseng and Ginkgo on Drug Disposition in Man$557,813
R01 · FY2003 · AT
Effects of Ginseng and Ginkgo on Drug Disposition in Man$560,735
R01 · FY2002 · AT
Effects of Ginseng and Ginkgo on Drug Disposition in Man$556,106
R01 · FY2001 · AT
PHASE I SINGLE &MULTIPLE-DOSE SAFETY &PHARMACOLOGY$0
N01 · FY2000 · CN
Phase I Single and Multiple dose Safety and Pharmacokine$0
N01 · FY2000 · CN